InvestorsHub Logo

Dapper10

05/26/21 7:51 PM

#5086 RE: cjstocksup #5039

Just viewed the video and was greatly impressed. Based on all time frames the doctor stated I believe we will be in good shape by College Football Season 1st week of September. Hopefully by then the SP will be much, much higher. Enjoy the rest of your day.

Sideem

05/27/21 7:25 AM

#5093 RE: cjstocksup #5039

Thanks for sharing the video link.

Skiluc

05/27/21 11:01 AM

#5155 RE: cjstocksup #5039

Must listen for every investor. Stickied.

Thank you.

Dragon Lady

06/01/21 9:49 AM

#5484 RE: cjstocksup #5039

Thanks for the link. Every QNTA shareholder needs to listen to the CC.
As requested, here is a link to the webinar from yesterday: https://vimeo.com/555299590




YES X 1,000 !!!

NASDAQ BOUND COMPANY and NASDAQ quality and "SEC BY THE BOOK" stellar good conference call !!


NEW QNTA aka Medolife Rx PR TODAY with MAJOR AD CAMPAIGN LAUNCH in Dominican which BY DEFAULT opens ALL OF LATIN AMERICA on June 1, 2021 NOW:

NEWS!!!Medolife Rx Launches National TV PSA Campaign Promoting
Escozine® and Activates Customer Service Center QNTA

June Boom is Here.

via NewMediaWire - Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCPINK:QNTA), announced today that it has launched a local national PSA-style TV ad campaign in the Dominican Republic (DR) promoting its lead drug candidate Escozine(R) as a natural alternative medicine for cancer treatment.

Additionally, the company has activated a customer service center in the DR that will enable it to better serve the needs of patients in the region.

The ad campaign and establishment of a customer service center comes as the Company recently received renewed product registration on Escozine(R) in the DR, enabling it to be sold as a natural alternative medicine for the treatment of cancer throughout Latin America.

The campaign is designed to create awareness and interest in Escozine(R). The Company is pursuing approval of additional therapeutic indications for Escozine(R) in the DR and is currently awaiting bioethics committee approval to begin its next phase of clinical trials.

Upon approval from the committee, Medolife will conduct a controlled, double-blind placebo trial on humans to validate the efficacy of Escozine(R) as a viable treatment.

This is in line with traditional regulatory approval practices, such as those in the United States, and the trial should take only a short time once approved.



STAP IN FOLKS - we all said JUNE WILL BE THE "NEWS" they won't waste it going into a long 3-day holiday weekend and IT IS JUNE 1 AND THEY JUST FIRED THE STARTING GUN FOR THE BIG RACE - we're in the pole position :)

QNTA aka MedoLife Rx now = IS GOING TO BE A MONSTER RUNNER HERE FOLKS and I mean a freaking MONSTER !!




Dragon Lady

06/01/21 11:20 AM

#5505 RE: cjstocksup #5039

QNTA: NEW_MedoLife Rx MERGER_Sr_Mgt TEAM_HAS_STELLAR_CREDENTIALS:

LOOK at the pedigree on their new CHIEF SCIENCE OFFICER who's going to get their product(s) and FDA IND real soon here - this is a TOP, TOP, TOP SHELF RESUME and NASDAQ WORTHY -

This stellar PhD/Med research cancer research expert didn't sign-on with this company to waste his time or reputation folks:

HARVARD MED for starters:)

https://ir.quantrx.com/company-information/management-team

QUOTE:

"Khalid Matalka, Ph.D., SI(ASCP)
Chief Scientific Officer


Professor Khalid Matalka received his BSc and MSc in Medical Technology in 1986 and 1988 from Yarmouk University, Jordan, and the University of Wisconsin-Milwaukee, USA. Then he received his Ph.D. in Pathology (Immunology and Cancer therapy) from Ohio State University, USA, in 1992.

After finishing his Ph.D., Dr. Matalka joined Harvard Medical School as a Postdoctoral fellow till 1994. He is an American Board Certified as a Specialist in Immunology (SI-ASCP) and a member at the American Society for Cancer Research since 1994.

Dr. Matalka enrolled in academia as an assistant professor in 1995, then promoted to associate and then a professor in 2004. Prof. Matalka held a dean position at two different academic institutions. Besides, Prof. Matalka was a consultant for twenty years to a JPM pharmaceutical company and a hospital diagnostic laboratory.

During those 22 years, Prof. Matalka was heavily involved in research mainly on immunomodulation, cancer research, and development of immunological assays. In 2016, he joined a pharmaceutical startup company named OncoTherapeutica, MA as a Chief Biologist.

While there, Prof. Matalka was developing new potential drugs for the treatment of prostate cancer and melanoma. In March 2020, Prof. Matalka joined Medolife Corporation as Chief Scientific Officer (CSO) and, in February 2021, became the CSO of the newly established Medolife Rx.

Prof. Matalka has 65 publications in peer-reviewed international journals, and he is an Associate Editor of two and a member of the editorial board of several international journals.

Prof. Matalka is known as an international reviewer in the fields of Cancer therapy, Immunomodulation, and Ethnopharmacology.
"

NIiiiiiice and WOW !!

FDA is going to sit-up and take this dude seriously when HE SUBMITS and SIGNS THEIR IND APPLICATIONS and CLINICAL DATA REPORTS etc !

HARVARD MED - among other top shelf name droppers and 65 PEER REVIEW journal pubs = BIG HITTER TERRITORY !!


Dragon Lady

06/07/21 9:05 AM

#6210 RE: cjstocksup #5039

Thanks for the link. Every QNTA shareholder needs to listen to the CC.
As requested, here is a link to the webinar from yesterday: https://vimeo.com/555299590



YES !!

AND NOW - every investor needs to LISTEN TO THE MedoLife Rx MGT UPDATE TOMORROW ON June 8th, 2021 INVESTOR UPDATE WEBCAST :)

They did NOT schedule a conference call ON A TUESDAY for no reason :)



https://www.newmediawire.com/news/medolife-rx-schedules-investor-webcast-for-tuesday-june-8-2021-5271459

Dragon Lady

06/17/21 10:18 AM

#7005 RE: cjstocksup #5039

$QNTA_Medolife_Endorsement_Agreement_W/_Legendary_Skateboarder_Tony_Hawk

SOME MOD NEEDS TO STICKY A VERSION OF THIS PLEASE - THIS is huuuge news!

This dude has a MASSIVE following in the YOUTH to clear up to middle age category (all those 70's and 80's skateboarders love this guy and have money to spend now !) - his following on-line is like 6 MILLION plus and he's a known BRAND BUILDER PRO NOW !!


https://www.globenewswire.com/news-release/2021/06/17/2248966/0/en/Medolife-Rx-Signs-Product-Endorsement-Agreement-With-Legendary-Skateboarder-Tony-Hawk.html

https://tonyhawk.com/

THAT is a legend in not only skateboarding - but BY DEFAULT ALL SKATEBOARDERS "cross over" to SURFING and SNOW BOARDING ETC - he reaches ALL OF THEM and this will sell cannabis pain ointments and venom ointments and their entire product line in a HUGE WAY !!

BURBANK, Calif., June 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer products, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that the Company has entered into a major brand endorsement agreement with the legendary skateboarder Tony Hawk, who will help promote the Company’s ground breaking line of polarized cannabidiol (CBD) products.

Utilizing the company’s patented polarization technology, the new Aelia line of products offers the highest level of relief associated with overexertion, inflammation and injury.

The Company has been working on a rebrand of its nutraceutical product offerings over the last few months. The product line, renamed “Aelia,” pays homage to Medolife Rx’s founder Dr. Arthur Mikaelian’s last name and is pronounced A-lee-uh.

The Aelia brand will feature the extremely popular formulation of products previously marketed under Quanta, Inc., such as muscle rubs and tinctures, as well as some new highly innovative products in the areas of wound care, stress relief and sun care. All Aelia products leverage the patented polarization technology, making them the only products of their kind in existence.

The polarization technology increases the potency and absorption of the active ingredients which enhances their overall effectiveness. Polarization utilizes quantum biology to supercharge active ingredients such as CBD, Arnica, and Vitamin C, making them over 500% more effective compared to other non-polarized products in the market.

As a part of this relaunch, the Company has partnered with renowned skateboarder Tony Hawk, who will act as a brand ambassador of the Company’s unique, one-of-a-kind products.

The campaign is seen as a “best of the best,” partnering with the “best of the best”. The Aelia/Hawk campaign also focuses on a premium level healing relief for everyone from elite athletes like Tony Hawk to the everyday weekend warrior.

“We could not have asked for a more perfect fit in terms of finding a partner than Mr. Tony Hawk to support our nutraceutical line of CBD pain relief products,” said Medolife Rx CEO Dr. Arthur Mikaelian.

“Tony Hawk is a household name that is synonymous with achievement and excellence. Those are the same core values of our Aelia brand. Tony is an extremely dynamic and diverse athlete, capturing the support and adoration of fans from 6 to 60.

But they all have one thing in common. They enjoy speed and action. And with that often comes a fair amount of pain and injury. We are both honored and humbled that Tony chose to support our products, and we look forward to a long and fruitful relationship.”

“Because I’m still so active, I’m constantly looking for the most effective products for muscle pain relief, bruising and post skate recovery. Aelia consistently works well for me, so it’s my first choice,” added Tony Hawk.

Investors and consumers are encouraged to sign up for product updates at aeliastore.com/tony. The Company expects to introduce the newly branded line of products in the coming weeks.
"


QNTA is about to become a NEW CORPORATE NAME and NEW TICKER SYMBOL as MedoLife Rx and SALES ARE GOING TO GO OFF LIKE A SOUNDING ROCKET !!

Get the FDA IND for the Scorpion Venom CANCER TREATMENT - which will take Latin America and Asia like a freaking fire storm and we go to a $BUCK A SHARE for starters !!


ULTRA LOW FLOAT STOCK and NEW COMPANY MERGER w/ PRO LEVEL Sr Mgt = winner here folks :)




Dragon Lady

06/17/21 10:54 AM

#7030 RE: cjstocksup #5039

SONY_SPONSORS_TONY_HAWK and now QNTA_HAS_HIM :)

WHO does Tony Hawk mention FIRST in this 48 Ma MILLION VIEW YOUTUBE VIDEO - which is more views than ANY NBA GETS NOW "LIVE" - he mentions his sponsor SONY a pesky little corporation no one has heard of LOL !!!


He's got VIDEO GAMES + the NEW SPORTS MARKET aka ACTION SPORTS aka EXTREME SPORTS = who his target markets are !!!

48 Ma MILLION VIEWS on one single video - and he has 100's of them and is a LEGEND in EXTREME SPORTS who DO NOT TRUST OR LIKE "western medicine" but looove ALTERNATIVE TREATMENTS !!



FIRST WORDS HE SPEAKS (like a good NASCAR DRIVER) is to get his SPONSOR'S NAME SONY SONY SONY and now MEDOLIFE MEDLIFE MEDLIFE "ON CAMERA" before he says ANYTHING ELSE !!!!

https://tonyhawk.com/

Dragon Lady

06/17/21 5:47 PM

#7100 RE: cjstocksup #5039

QNTA: MedoLife Rx NEW_COMPANY_DEAD_SERIOUS_ON_MAJOR_BRAND_LAUNCH !

QNTA IS A MERGER STORY - a total makeover, I can NOT stress this enough folks !! It's now the MedoLife Rx story....and it's launching now....

Look at this - they NAILED IT and did the PR today and their websites are being changed = revenues are going to be HUGE from their consumer line ....and IMO will fund the FDA IND stuff and their heavy duty Scorpion Venom "cancer treatment" product lines into Latin America and Asia = $10's of millions in sales very rapidly.

https://finance.yahoo.com/news/medolife-rx-signs-product-endorsement-123000550.html

I SERIOUSLY BELIEVE we're looking at a NASDAQ bound company and Sr Mgt team here folks - and I full expect a CORP NAME CHANGE and STOCK TICKER CHANGE now as in "imminent" to tie-together ALL THIS NEW BRANDING LAUNCH and cut loose the old sleep QNTA baggage !

LOOK AT THIS FOLKS - they are LAUNCHING with a dude who's had a WORLD-WIDE On-GOING X-TREME sports career, a NY TIMES BEST SELLING BOOK, owns a film company now and is a MASTER BRANDER aka TONY HAWK !!

https://tonyhawk.com/partnerships/

https://tonyhawk.com/

AND NOW:

https://aeliastore.com/about-us/

https://aeliastore.com/tony-hawk/

LOOK AT THIS - WOW WOW WOW



CONSUMER BRANDS SIDE - which FUNDS THE SERIOUS "CANCER SCORPION VENOM TREATMENT PRODUCTS" side :




Dragon Lady

06/23/21 9:20 AM

#7565 RE: cjstocksup #5039

QNTA: Huuge_FDA_IND_UPDATE as_in HUGE_POSITIVE !!!

https://ih.advfn.com/stock-market/USOTC/quanta-pk-QNTA/stock-news/85427410/fda-accepts-medolife-rxs-covid-19-clinical-study

https://www.globenewswire.com/news-release/2021/06/23/2251802/0/en/FDA-Accepts-COVID-19-Clinical-Study-and-Advises-on-Next-Steps-for-Pre-IND-Filing-by-Medolife-Rx.html

THIS IS MEGA HUGE FOLKS - they're a micro step away from bagging this FDA IND which will send this stock to a $BUCK A SHARE !!!

I am personally VERY familiar with the FDA IND process- and THIS is a 100% positive update and means the FDA is VERY VERY close to granting that IND to QNTA aka MedoLife Rx !!

An IND and the parallel IRB - Institutional Review Board Protocol(s) which is what will govern and control ALL CLINIC TRIALS TO FOLLOW is ALWAYS a back-n-forth affair between the one submitting (QNTA aka MedoLife Rx) and their FDA assigned case handler - WHEN DONE BY THE BOOK and DONE RIGHT !!

QNTA's aka MedoLife Rx their NEW CHIEF SCIENCE OFFICER has a Harvard Med and 65 PEER reviewed journal background and a HELL OF A LOT OF FDA SUBMISSIONS "under his belt" = he will get this over the finish line.

THE FDA WOULD NOT accept the submitted COVID CLINICAL DATA if they had no interest or belief to GRANT AND APPROVE THE IND for MedoLife Rx !!

FOLKS - BUY QNTA NOW as when that "IND GRANTED" PR hits, wild horses won't be able to hold this monster back !!!

QNTA is about to become a NEW CORPORATE NAME and NEW TICKER SYMBOL as MedoLife Rx and SALES ARE GOING TO GO OFF LIKE A SOUNDING ROCKET !!

Get the FDA IND for the Scorpion Venom CANCER TREATMENT - which will take Latin America and Asia like a freaking fire storm and we go to a $BUCK A SHARE for starters !!


ULTRA LOW FLOAT STOCK and NEW COMPANY MERGER w/ PRO LEVEL Sr Mgt = winner here folks :)




Dragon Lady

06/29/21 9:43 AM

#8043 RE: cjstocksup #5039

QNTA: MAJOR_NEW_PARTNERSHIP_NEWS_THIS_AM "Target MEXICO" !!

MedoLife Rx is GOING AFTER MEXICO FOLKS - Biiiig market !!

SALES and REVENUE WILL DRIVE THE STOCK PRICE - ALWAYS !

https://www.globenewswire.com/news-release/2021/06/29/2254737/0/en/Medolife-Rx-Enters-Partnership-Agreement-with-Leading-International-Distributor-Brings-Products-to-Mexico.html

https://finance.yahoo.com/news/medolife-rx-enters-partnership-agreement-123000718.html


THEIR CLIENT LIST IS EXTENSIVE - they get "consumer brands" CREATED IN SPANISH aka TO A "MEXICAN" audience and "inside" stores in that country as "household names" etc !

I said it before folks - they're going for LATIN AMERICA, ASIA, EASTERN EUROPE etc.

NO need to wait on the U.S. FDA - there's a MASSIVE population and sales base to be had GLOBALLY and THAT is where the "big money" is at !!

QUOTE:


Xoles,Mexico: The exclusive partnership agreement grants Xoles the sole opportunity to market and sell Medolife’s proprietary product line throughout Mexico through its broad network with thousands of retail locations, as well as through various direct-to-consumer e-commerce channels.

Xoles has strong relationships throughout the country with the largest drugstore chains and global big box retailers.

Distribution will include Medolife’s leading product line, called Immunapen™, that includes four formulations specifically designed to promote general wellness aspects of consumers’ lives such as sleep, immunity support, anti-anxiety, and energy and focus.

This product line was created in response to the COVID-19 pandemic to address health concerns revolving around immunity, stress, anxiety and lack of energy.

The Immunapen™ product line contains a natural version of the peptides used in the Company’s lead drug candidate Escozine® that are amplified by Medolife’s proprietary polarization technology.
"

END QUOTE

https://medolife.com/







Dragon Lady

06/30/21 10:40 AM

#8153 RE: cjstocksup #5039

Where_will_MEDICAL_R&D_and CLINICAL_TRIALS_GET_SCORPION_VENOM ???

KEEP THE EYE ON THE BIG PRIZE HERE FOLKS - the "consumer" product line is great and can drive huuuge sales (ICY HOT is a $150 ma MILLION company as a simple example) but the PHARMA GRADE venoms - is no freaking joke the "medical world" and "academia research" !!

Venom research (VERY unique peptides and proteins with proven tumor killing ability, etc) is making great strides and they NEED TO GET IT FROM SOMEPLACE - as cancer researchers ain't gonna make it themselves !!

They will BUY IT as PHARMA GRADE from a supplier like - uh QNTA aka MedoLife Rx, THAT IS HOW !!

MD's and PhD researchers at universities and in academia and in R&D hospitals running CANCER or COVID TRIALS using "scorpion venom" are NOT going to sit around "trying" to learn how to milk a few micro drops of the liquid gold venom out of live scorpions !!

It's an extremely detailed and elaborate process to "farm" the scorpions and then a method that actually uses a tiny electrical charge on the "stinger tip" allows a manufacturing facility to capture a micro drop or two from each scorpion - THIS IS QNTA now via their MedoLife Rx merger !!

QNTA will now supply a HIGHLY IN DEMAND PHARMA PRODUCT as R&D for these venom trials explodes- QNTA will become PHARMA SUPPLIERS via a FDA/cGMP (Current good manufacturing practices) certified mass production plant -

And they are selling literal LIQUID GOLD that may hold the cure or adjunct cure for many cancers and tumors and even COVID in the future -


http://medolife.com/facilities/

The stuff they produce is $1,000's per bottle that a "clinical trial" of say even 20 patients may use by the 100's and 100's of bottles over a course of just a few weeks as one example !



THAT = THE FUTURE RIGHT THERE FOLKS and sleepy lil QNTA OWNS IT ALL NOW and PATENTS WITH IT :)

Dragon Lady

07/02/21 10:04 AM

#8246 RE: cjstocksup #5039

QNTA: OTCQB UP-LIST FILED SEC 8-K !!

https://ih.advfn.com/stock-market/USOTC/quanta-pk-QNTA/stock-news/85504830/current-report-filing-8-k

QNTA aka soon to be MedoLife Rx is MOVING ON UP :)

QUOTE:

"Item 8.01 Other Events.

On July 1, 2021, the Company filed an application for the OTCQB Venture Market. The Company’s securities are currently quoted on OTC Markets Group’s Pink Open Market tier. According to OTC Markets Group, the OTCQB® Venture Market is for entrepreneurial and development stage U.S. and international companies.

To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. Companies must meet $0.01 bid test.
"


VERY GOOD SIGN - this new Sr Mgt crew and WHOLE NEW COMPANY is confident of where they're heading folks !!

Inking MAJOR distribution and sponsorship deals to rapidly grow their consumer product sales growth = sales and revenues DRIVE THE SHARE PRICE !

A company MUST BE OTCQB FIRST - before ever making a "go" at a NASDAQ UP-LISTING one day, which this new Mgt team has stated is their end-game here :)

Dragon Lady

07/27/21 3:57 PM

#9095 RE: cjstocksup #5039

Big day QNTA aka MedoLife Rx- ers :)

Hello cjstocks !! Hope all is well :)

Please help get the msg out that AFTER MARKET TODAY is the big ole QNTA aka MedoLife "CEO LIVE WITH ANY QUESTIONS ASKED" update Zoom call "live" they are giving AT SHAREHOLDER REQUEST !!!


This "investor call" live, was a direct result of people emailing the company and several speaking to them by phone or ZOOM and the CEO personally set-up THIS CALL TODAY as he wants to be up-front and answer any and all questions !!

LETS GET THE WORD OUT - LOTS of updates and info believed to be discussed on this call, as in LOTS :

https://twitter.com/AELIAstore/status/1419791168271912972

QUOTE:

"See what's up next for MEDOLIFE & AELIA at the Investors webcast tomorrow! Get more details here https://zcu.io/Gh7M Also, take advantage of QuantRx.com inventory liquidation and save 25% on all products!
"


"Tomorrow" = TODAY as that Tweet was late yesterday !!

https://finance.yahoo.com/news/medolife-rx-schedules-investor-webcast-150400404.html?guccounter=1

To register for this webcast, please use the below web link.

https://zoom.us/webinar/register/WN_q2EAvbt-QpiDMhYj_ToWFg

THAT is the "live link" to participate and listen-in on the ZOOM call with the company CEO and Sr Mgt :)

Dapper10

12/03/21 12:23 PM

#11592 RE: cjstocksup #5039

By mid next week this stock will be .009 or below. Headed to .0001. Piss poor CEO. Nothing but a big bag of wind.

JediMozart

12/03/21 7:37 PM

#11602 RE: cjstocksup #5039

Listen starting at 6:23 he’s discussing length of time it takes for various things
One example, the polarization technology patent was applied for in 2007 then subsequently they received patent approval 2010 ( also noting It was mentioned prior to this time mark, they’ve been studying the scorpion peptide for over 17 years)
It’s worth going back and relistening to these CCs as the time frames all make much more sense … the company is literally at a precipice and IMO (while believe me I know it’s tough) patience it’s what’s needed here … dr Makaelian has put forth a life time of work bringing the escozine and polarization technology to where it is now … unfortunately covid brought with it huge bumps in the road but also brought with it a unique opportunity to help move this orphan drug along a little quicker … everything in life can be seen more calmly when in proper perspective… while on one hand things seem to be taking forever … compared to some drug paths this is actually moving along at a good pace. It’s all relative.
Happy Friday every one … grab a note book and a drink and relisten to all the CCs starting with this one … it’ll make the current sp less cringeworthy
GLTA
QNTA MedolifeRx escozine $cience

https://vimeo.com/555299590